Abstract

IntroductionAnabolic androgenic steroids (AAS), including testosterone and synthetic derivatives, are typically used to increase muscle mass. Many users develop a dependence on these substances, contributing to worsened physical and mental health outcomes. Aspects of personality and executive dysfunction may represent underlying vulnerabilities for developing dependence. ObjectiveTo identify levels of AAS dependence within substance use disorder (SUD) treatment patients and assess the relationship between dependence severity and personality traits and executive function (EF). MethodsData were collected from patients at 38 SUD treatment facilities in Norway. Questionnaires were completed for measures of personality and EF. Measures of symptoms of AAS dependence were used in latent class analysis to identify sub-groups of patients, which were evaluated for association with EF and personality traits, and compared with a group of non-AAS using SUD patients. ResultsThree classes were identified; largely reflecting low, moderate, and high symptoms of dependence. Multinomial regression analyses indicated that moderate and high symptoms were associated with several measures of EF and personality traits, particularly self-monitoring, antagonism, disinhibition, and rigid perfectionism while users with low symptoms exhibited higher capacities for emotional control and shift, and lower negative affectivity, relative to non-AAS using SUD patients. Backward stepwise regressions indicated antagonism, and decreased self-monitoring as key personality and cognitive characteristics of SUD patients with severe AAS dependence. ConclusionOur findings indicate that specific executive dysfunctions and personality features, particularly those associated with poor emotional control, reduced empathy, and impulsivity are associated with more severe AAS dependence in the SUD population.

Highlights

  • Anabolic androgenic steroids (AAS), including testosterone and synthetic derivatives, are typically used to increase muscle mass

  • Measures of symptoms of AAS dependence were used in latent class analysis to identify sub-groups of patients, which were evaluated for association with executive function (EF) and personality traits, and compared with a group of non-AAS using substance use disorder (SUD) patients

  • Multinomial regression analyses indicated that moderate and high symptoms were associated with several measures of EF and personality traits, self-monitoring, antagonism, disinhibition, and rigid perfectionism while users with low symptoms exhibited higher capacities for emotional control and shift, and lower negative affectivity, relative to non-AAS using SUD patients

Read more

Summary

Introduction

Anabolic androgenic steroids (AAS), including testosterone and synthetic derivatives, are typically used to increase muscle mass. Anabolic-androgenic steroids (AAS) include testosterone and synthetic derivatives, which are primarily used by athletes and weight-lifters to increase muscle mass. In order to characterize relevant individual differences in AAS dependence within this group, a dimensional approach may be beneficial This approach reflects the recent changes towards more individualized care in psychiatry, as demonstrated by the Diagnostic and Statistical Manual, 5th edition, and the Eleventh Revision of the International Classification of Diseases which include levels of severity within SUD (American Psychiatric Association, 2013; World Health Organization, 2019)

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.